Trial Profile
A Multicenter Open-label Phase IV Trial of Imrecoxib in Treatment of Knee Osteoarthritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2013
Price :
$35
*
At a glance
- Drugs Imrecoxib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 25 Nov 2013 New trial record